Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Mechanisms and Novel Therapeutic Approaches for Gynecologic Cancer
| Mechanisms and Novel Therapeutic Approaches for Gynecologic Cancer |
| Autore | Nakayama Naomi |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (258 p.) |
| Soggetto topico | Public health and preventive medicine |
| Soggetto non controllato |
adoptive immunotherapy
anti-angiogenic therapy aryl hydrocarbon receptor BEN (BANP, E5R and NAC1) domain biological planning biomarkers borderline ovarian tumors BRCA1 mutant ovarian cancer cancer progression CD44 cervical cancer cervical neoplasia chimeric antigen receptor clear cell carcinoma differentially expressed genes DNA damage response DNA mismatch repair (MMR) drug repurposing endometrial cancer endometrial carcinoma endometrioid endometrial cancer epithelial ovarian cancer epithelial ovarian cancers epithelial-mesenchymal transition exosome gene ontology gynecological cancer HDR brachytherapy human cytomegalovirus immune checkpoints inhibitors immune micro-environment immunohistochemistry immunosuppression in vivo dosimetry inflammation integrative analysis interventional radiotherapy isothermal titration calorimetry (ITC) liquid biopsy long-term survival melanoma treatment microsatellite instability miRNA mismatch repair deficiency MMR deficient (dMMR) n/a nanocarriers NK cells non-coding RNAs nucleus accumbens-associated protein 1 (NAC1) ovarian cancer p16 protein pGSK3β PLA2G7) platelet-activating factor acetylhydrolase (PAF-AH prognosis sequence-specific DNA-binding protein solution NMR structure somatic mutation targeted therapy testin vaginal melanoma vaginal-cuff brachytherapy vulvar melanoma Wnt signaling β-catenin |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910580209103321 |
Nakayama Naomi
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Targeting Wnt Signaling in Cancer: Opportunities Abound If We Can Avoid the Sword of Damocles
| Targeting Wnt Signaling in Cancer: Opportunities Abound If We Can Avoid the Sword of Damocles |
| Autore | Kahn Michael |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (298 p.) |
| Soggetto topico |
Medicine and Nursing
Pharmacology |
| Soggetto non controllato |
AML
angiogenesis anti-angiogenic therapy APC astrocytic brain tumors cancer cancer stem cells cancer therapy CBP cell adhesion colitis colon cancer colorectal colorectal cancer DKKs drug discovery drug target EMT fibrosis fungi secondary metabolite derivative gastrointestinal cancers GSK3β HBV hepatitis B virus IBD immune checkpoint inhibitor immunotherapy immunotherapy resistance invasion and metastasis just-right signaling L1 Lgr5 liver cancer microenvironment molecular targeting molecular therapeutics Musashi MYC NCB-0846 NF-κB Notch signaling p300 pancreatic cancer pancreatic stellate cells pancreatitis porcupine precision medicine R-spondin RNA-binding proteins serrated signaling synovial sarcoma TCF/LEF therapeutic targeting of Wnt signaling TNIK tumor immunology tumor metabolism urothelial cancer vitamin D wnt Wnt Wnt signaling Wnt target genes Wnt/beta-catenin signaling β-catenin β-catenin mutations β-catenin paradox |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Targeting Wnt Signaling in Cancer |
| Record Nr. | UNINA-9910566469503321 |
|
Kahn Michael
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||